Supplemental material
Journal of Medical Economics
Volume 27, 2024 - Issue 1
Oncology
Value of next generation sequencing (NGS) testing in advanced cancer patients
Jesse D. Ortendahla Partnership for Health Analytic Research (PHAR), LLC, Beverly Hills, CA, USA
https://orcid.org/0009-0002-6808-8267View further author information
https://orcid.org/0009-0002-6808-8267View further author information, Gebra Cuyun Carterb Exact Sciences Corporation, Madison, WI, USACorrespondence[email protected]
https://orcid.org/0000-0002-6549-0069View further author information
https://orcid.org/0000-0002-6549-0069View further author information, Snehal G. Thakkarb Exact Sciences Corporation, Madison, WI, USAhttps://orcid.org/0009-0000-8363-4727View further author information
https://orcid.org/0009-0000-8363-4727View further author information, Katalin Bognara Partnership for Health Analytic Research (PHAR), LLC, Beverly Hills, CA, USAhttps://orcid.org/0000-0001-8357-8569View further author information
https://orcid.org/0000-0001-8357-8569View further author information, David W. Hallb Exact Sciences Corporation, Madison, WI, USAhttps://orcid.org/0000-0001-7708-6656View further author information
https://orcid.org/0000-0001-7708-6656View further author information & Yara Abdouc UNC Health Care, Chapel Hill, NC, USAhttps://orcid.org/0000-0002-4827-8613View further author information
https://orcid.org/0000-0002-4827-8613View further author information